Alzprotect Overview

  • Founded
  • 2007
Founded
  • Status
  • Private
  • Employees
  • 6
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $7.62M
Latest Deal Amount
  • Investors
  • 6

Alzprotect General Information

Description

Developer of therapeutic drugs intended to stop neurodegeneration in order to fight Alzheimer's disease. The company's drug includes drug candidate AZP2006: AZP2006, which differs significantly from the molecules developed so far by the pharmaceutical industry, enabling doctors to help in the treatment of neurodegenerative diseases including Alzheimer's disease (AD) and orphan tauopathies such as Progressive Supranuclear Palsy (PSP).

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Primary Office
  • 85 Rue Nelson Mandela
  • 59120 Loos
  • France
+33 09 00 00 00 00

Alzprotect Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Alzprotect Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC 26-Dec-2018 $7.62M 000.00 000.00 Completed Clinical Trials - Phase 1
11. Later Stage VC (Series B) 22-Jan-2018 000.00 000.00 Completed Clinical Trials - Phase 1
10. Equity Crowdfunding 15-Feb-2017 00.000 Completed Generating Revenue
9. Later Stage VC 28-Dec-2016 00.000 00.000 000.00 Completed Generating Revenue
8. Later Stage VC 02-Sep-2015 00.000 00.00 000.00 Completed Generating Revenue
7. Later Stage VC (Series A) 11-Jun-2014 00.000 00.000 00.000 Completed Generating Revenue
6. Later Stage VC 28-Jun-2013 00000 00.000 00.000 Completed Generating Revenue
5. Early Stage VC 15-Jun-2012 00000 00.000 00.000 Completed Generating Revenue
4. Early Stage VC 22-Dec-2011 $134K $858K 00.000 Completed Generating Revenue
3. Early Stage VC 11-May-2010 $251K $724K 00.000 Completed Generating Revenue
To view Alzprotect’s complete valuation and funding history, request access »

Alzprotect Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
X Shares 000,000 00.000000 000.00 000.00 00 000.00
X Shares 00,000 00.000000 000.00 000.00 00 000.00
O Shares 00,000 00.000000 000.00 000.00 00 000.00
O Shares 00,000 00.000000 000.00 000.00 00 000.00
O Shares 00,000 00.000000 000.00 000.00 00 000.00
O Shares 00,000 00.000000 000.00 000.00 00 000.00
O Shares 00,000 00.000000 000.00 000.00 00 000.00
O Shares 0,000 00.000000 000.00 000.00 00 000.00
O Shares 9,500 $1.136628 $22.73 $22.73 1x $22.73
O Shares 5,250 $1.136628 $22.73 $22.73 1x $22.73
To view Alzprotect’s complete cap table history, request access »

Alzprotect Executive Team (5)

Name Title Board Seat Contact Info
Philippe Verwaerde Ph.D Chief Executive Officer, President, Scientific Director, Chairman & Chief Scientific Officer
André Delacourte Ph.D Co-Founder
Patricia Melnyk Ph.D Co-Founder
You’re viewing 3 of 5 executive team members. Get the full list »

Alzprotect Board Members (9)

Name Representing Role Since
François-René Letourneur Self Board Member 000 0000
Jacqueline Lecourtier Ph.D Alzprotect Board Member 000 0000
Pierre Besançon Alzprotect Board Member 000 0000
Pierre Le Sourd Alzprotect Board Member 000 0000
You’re viewing 4 of 9 board members. Get the full list »

Alzprotect Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alzprotect Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
University of Lille Foundation Limited Partner Minority 000 0000 000000 0
Xerys Gestion PE/Buyout Minority 000 0000 000000 0
Finovam Gestion Venture Capital Minority 000 0000 000000 0
Nord France Amorçage Venture Capital Minority 000 0000 000000 0
Finorpa Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »